Anti Depressants

Femodene Generic Gestodene

Anti Depressants » Prescription Drugs 7 » Femodene Generic Gestodene

FEMODENE 28: The memo-pack holds 21 white tablets diameter 5.7 mm containing 0.075 mg gestodene and 0.030 mg ethinylestradiol and in addition 7 larger white non-hormonal tablets diameter 6.8 mm.Indications:Oral contraceptionDosage and Administration:Combined oral contraceptives such as FEMODENE 28 when taken correctly have a failure rate of approximately 1% per year. The failure rate may increase when pills are missed or taken incorrectly.How to Take FEMODENE 28:Tablets must be taken in the order directed on the package every day at about the same time with some water as needed. Tablet-taking is continuous. One tablet is to be taken daily for 28 consecutive days. Each subsequent pack is started the day after the last tablet of the previous pack following the directional arrows. Withdrawal bleeding usually occurs while taking the 7 non-hormonal tablets. This usually starts on day 2 - 3 after starting the non-hormonal tablets and may not have finished before the next pack is started.How to Start FEMODENE 28:START WITH THE FIRST TABLET FROM THE GREEN SECTION MARKED WITH THAT DAY OF THE WEEK in accordance with one of the following:No preceding hormonal contraceptive use (in the past month) Tablet taking has to start on day 1 of the woman's natural cycle (i.e. the first day of her menstrual bleeding). Starting on days 2 - 3 is allowed but during the first cycle an additional barrier contraceptive method is recommended for the first 7 days of tablet taking.Changing from another combined oral contraceptive (COC) vaginal ring or transdermal patch The woman should start with FEMODENE 28 preferably on the day after the last hormonal tablet of her previous COC but at the latest on the day following the usual tablet-free or non-hormonal tablet interval of her previous COC.In case a vaginal ring or transdermal patch has been used the woman should start using FEMODENE 28 preferably on the day of removal but at the latest when the next application would have been due.Changing from a progestogen-only method (minipill injection implant) or progestogen-releasing intrauterine system (IUS) The woman may switch any day from the minipill from an implant or IUS on the day of its removal or from an injectable when the next injection would be due. In all of these cases the woman should be advised to additionally use a barrier contraceptive method for the first 7 days of tablet taking.Following first-trimester abortion The woman may start immediately. When doing so she need not take additional contraceptive measures.Following delivery or second-trimester abortion The woman should be advised to start at day 21 to 28 after delivery or second-trimester abortion. When starting later than this the woman should be advised to additionally use a barrier contraceptive method for the first 7 days of tablet taking. However if intercourse has already occurred pregnancy should be excluded before starting FEMODENE 28 or the woman has to wait for her first menstrual period.Management of Missed TabletsErrors in taking the non-hormonal tablets contained in FEMODENE 28 can be ignored. However they should be discarded to avoid unintentionally prolonging the placebo tablet phase. The following advice only refers to missed non-hormonal tablets:If the user is less than 12 hours late in taking any hormonal tablet contraceptive protection is not reduced. The woman should take the tablet as soon as she remembers and should take subsequent tablets at the usual time.If she is more than 12 hours late in taking any hormonal tablet contraceptive protection may be reduced.There is a particularly high risk of pregnancy if tablets are missed just before or immediately after taking the non-hormonal tablets. If tablets are missed in the first week of taking hormonal tablets following the non-hormonal tablets and intercourse took place in the preceding 7 days the possibility of pregnancy should be considered.The management of missed tablets can be guided by the following two basic rules:Tablet taking must never be discontinued for longer than 7 days. Seven days of uninterrupted tablet taking are required to attain adequate suppression of the hypothalamic-pituitary-ovarian axis. These rules form the basis of the instructions to patients provided in the package insert.

Buy Femodene Generic Gestodene and other Prescription Drugs 7 products online at Medstore.

Buy Online at Medstore - Click Here!

About Femodene Generic Gestodene:

Product Type: Prescription Drugs 7

Femodene ( Generic Gestodene/Ethinylestradiol )

Femodene (Generic Gestodene/Ethinylestradiol)

Generic Gestodene/Ethinylestradiol

0.075/0.030mg 84(3 x 28) Tablets 168(6 x 28) Tablets Generic Gestodene/Ethinylestradiol Femodene

View more Prescription Drugs 7

Previous Product  Next Product

Anti Depressants: Anafranil (Clomipramine HCI) Anafranil (Clomipramine HCI) is a tricyclic antidepressant used to treat depression and obsessive-compulsive disorder. Buy Anafranil (Clomipramine HCI) and other Anti Depressants products online at Medstore. About Anafranil (Clomipramine HCI): Product Type: Anti Depressants Brand name: Anafranil Generic name: Clomipramine HCI What is the most important information I should know about Anafranil? • While you are taking Anafranil you may need to be monitored for worsening symptoms of depression and/ or suicidal thoughts at the start of therapy or when doses are changed. This concern about the increased risk of suicidal thoughts or behaviors may be greater if you are 18 years of age or younger and are taking Anafranil. In patients younger than 18 years the period of risk may extend beyond start of therapy or when doses are changed. Your doctor may want you to monitor for the following symptoms: anxiety panic attacks difficulty sleeping irritability hostility impulsivity severe restlessness and mania (mental and/ or physical hyperactivity). These symptoms may be associated with the development of worsening symptoms of depression and/ or suicidal thoughts or actions. Contact your healthcare provider if you develop any new or worsening mental health symptoms during treatment with Anafranil. Do not stop taking Anafranil. • It may be 4 weeks or more before you start to feel better but do not stop taking Anafranil without first talking to your doctor. • Use caution when driving operating machinery or performing other hazardous activities. Anafranil may cause drowsiness or dizziness. If you experience drowsiness or dizziness avoid these activities. • Dizziness is likely to occur when you rise from a sitting or lying position. Rise slowly to prevent dizziness and a possible fall. • Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while you are taking Anafranil. What is Anafranil? • Anafranil is in a class of drugs called tricyclic antidepressants. Anafranil affects chemicals in the brain that may become unbalanced and cause obsessive-compulsive disorder. • Anafranil is used to relieve symptoms of obsessive-compulsive disorder such as recurrent thoughts or feelings and repetitive actions. • Anafranil may also be used for purposes other than those listed in this medication guide. What should I discuss with my healthcare provider before taking Anafranil? • Do not take Anafranil if you have taken a monoamine oxidase inhibitor such as isocarboxazid (Marplan) phenelzine (Nardil) or tranylcypromine (Parnate) within the last 14 days. • Before taking Anafranil tell your doctor if you have liver disease kidney disease asthma thyroid disease diabetes stomach or intestinal problems high blood pressure or heart disease had a heart attack in the last 6 weeks an enlarged prostate or difficulty urinating glaucoma or seizures. • You may not be able to take Anafranil or you may require a dosage adjustment or special monitoring during therapy if you have any of the conditions listed above. • While you are taking Anafranil you may need to be monitored for worsening symptoms of depression and/ or suicidal thoughts at the start of therapy or when doses are changed. This concern about the increased risk of suicidal thoughts or behaviors may be greater if you are 18 years of age or younger and are taking Anafranil. In patients younger than 18 years the period of risk may extend beyond start of therapy or when doses are changed. Your doctor may want you to monitor for the following symptoms: anxiety panic attacks difficulty sleeping irritability hostility impulsivity severe restlessness and mania (mental and/ or physical hyperactivity). These symptoms may be associated with the development of worsening symptoms of depression and/ or suicidal thoughts or actions. Contact your healthcare provider if you develop any new or worsening mental health symptoms during treatment with Anafranil. Do not stop taking Anafranil. • Anafranil is in the FDA pregnancy category C. This means that it is not known whether Anafranil will harm an unborn baby. Do not take Anafranil without first talking to your doctor if you are pregnant or could become pregnant during treatment. • Anafranil passes into breast milk and may affect a nursing baby. Do not take Anafranil without first talking to your doctor if you are breast-feeding a baby. How should I take Anafranil? • Take Anafranil exactly as directed by your doctor. If you do not understand these directions ask your pharmacist nurse or doctor to explain them to you. • Take each dose with a full glass (8 oz) of water. • Anafranil may be taken several times a day or in one daily dose (usually at bedtime). Follow your doctor's instructions. • Grapefruit and grapefruit juice may interact with Anafranil. The interaction could lead to potentially dangerous effects. Discuss the use of grapefruit and grapefruit juice with your doctor. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor. • It may be 4 weeks or more before you start to feel better but do not stop taking Anafranil without first talking to your doctor. • Store Anafranil at room temperature away from moisture and heat. What happens if I miss a dose? • Take the missed dose as soon as you remember. If it is almost time for the next regularly scheduled dose skip the missed dose and take the next one as directed. Do not take a double dose of this medication unless otherwise directed by your doctor. What happens if I overdose? • Seek emergency medical attention. • Symptoms of a Anafranil overdose include seizures confusion drowsiness agitation hallucinations and low blood pressure (dizziness fatigue fainting). What should I avoid while taking Anafranil? • Use caution when driving operating machinery or performing other hazardous activities. Anafranil may cause drowsiness or dizziness. If you experience drowsiness or dizziness avoid these activities. • Dizziness is likely to occur when you rise from a sitting or lying position. Rise slowly to prevent dizziness and a possible fall. • Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while you are taking Anafranil. • Grapefruit and grapefruit juice may interact with Anafranil. The interaction could lead to potentially dangerous effects. Discuss the use of grapefruit and grapefruit juice with your doctor. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor. • Do not stop taking Anafranil suddenly. This could cause symptoms such as nausea headache and malaise. What are the possible side effects of Anafranil? • If you experience any of the following serious side effects stop taking Anafranil and contact your doctor immediately or seek emergency medical treatment: an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips face or tongue; or hives); seizures; a fast or irregular heartbeat; a heart attack; high blood pressure (blurred vision severe headache); difficulty urinating; or fever with increased sweating muscle stiffness or severe muscle weakness. • Other less serious side effects may be more likely to occur. Continue to take Anafranil and talk to your doctor if you experience drowsiness or dizziness; dry mouth and eyes; constipation; mild tremor; sweating; mild agitation weakness or headache; ringing in the ears; nausea; or loss of weight or appetite. • Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. What other drugs will affect Anafranil? • Do not take Anafranil if you have taken a monoamine oxidase inhibitor such as isocarboxazid (Marplan) phenelzine (Nardil) or tranylcypromine (Parnate) within the last 14 days. • Anafranil may increase the effects of other drugs that cause drowsiness including other antidepressants alcohol antihistamines sedatives (used to treat insomnia) pain relievers anxiety medicines and muscle relaxants. Tell your doctor about all medicines that you are taking and do not take any other prescription or over-the-counter medicines without first talking to your doctor. • Drugs other than those listed here may also interact with Anafranil. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines including herbal products. Generic Anafranil (Clomipramine HCI) Clonil Tridep Clomipraminum Hydiphen Monochlorimipramine 10mg 100 tabs 10mg 200 tabs 50mg 100 tabs 25mg 100 tabs 50mg 50 tabs 10mg 300 tabs 50mg 150 tabs 25mg 200 tabs 75mg 100 tabs 10mg 400 tabs 50mg 200 tabs 25mg 300 tabs 75mg 150 tabs 10mg 800 tabs 50mg 400 tabs 25mg 400 tabs 75mg 200 tabs 25mg 800 tabs 75mg 400 tabs 75mg 50 tabs Clomipramine HCI Anafranil